PlainRecalls
FDA Devices Moderate Class II Ongoing

Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"

Reported: September 22, 2021 Initiated: March 1, 2021 #Z-2452-2021

Product Description

Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"

Reason for Recall

The kit does not have an emergency use authorization (EUA).

Details

Recalling Firm
Cellex
Units Affected
Approximately 44,821 kits
Distribution
US Nationwide distribution in the states of CA, FL, TX, and WI.
Location
Morrisville, NC

Frequently Asked Questions

What product was recalled?
Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue". Recalled by Cellex. Units affected: Approximately 44,821 kits.
Why was this product recalled?
The kit does not have an emergency use authorization (EUA).
Which agency issued this recall?
This recall was issued by the FDA Devices on September 22, 2021. Severity: Moderate. Recall number: Z-2452-2021.